Neurology/Psychiatry
Clearer Direction for Complex Neurology and Psychiatry Development
When symptoms fluctuate, endpoints are subjective, and disease progression varies, the wrong study assumption can obscure a signal that matters to patients.
Neurology and psychiatry programs often ask sponsors to make high-stakes decisions from difficult-to-interpret signals.
In the past five years, Veristat has supported more than 200 clinical trials and consulting projects across neurodegenerative disorders, pain management, and mental health. Our teams connect study design, patient realities, biometrics, clinical execution, and regulatory strategy so data can provide clearer direction for the next development decision.
200+
clinical trials and consulting projects in five years across neurodegenerative disorders, pain management, and mental health.
Subjective endpoints, variable disease progression, complex patient populations, and safety considerations can each change how the data should be interpreted.
Veristat helps sponsors anticipate those risks, build decision-ready evidence, and keep the clinical and regulatory path aligned from early planning through submission.
Start with the decision your CNS or neurology program needs to support next, then connect the right expertise across:
- Pre-Clinical/Trial Planning to increase speed
- Study Design and Methodology that works
- Development of regulatory strategy, expedited pathways, and regulatory agency interactions
- Clinical program planning, inclusive of statistical planning and analysis
- Agile patient recruitment strategies to support virtual trial and hybrid approaches
- Marketing Application Preparation and Publishing
- Post-Market Pharmacovigilance to ensure safety
CASE STUDY
Global Pediatric Full-Service Phase I/II Clinical Trial Begins on Heels of Successful Natural History Study
A mid-sized biotech company sought Veristat early in development for help with a natural history trial. After its successful implementation, the sponsor moved forward with the gene therapy treatment program, which has already treated its first patients. Read how Veristat continues to provide full-service support for this Phase 1/2 clinical trial.
Read the Case Study →
40+
Full-service biologics
trials successfully conducted
in the past three years
From regulatory strategy and biostatistics to site management and patient relocation, Veristat served as an extension of the sponsor team to advance an ultra-rare pediatric gene therapy program.
Scientific Excellence Across Neurology Therapy Development
Our depth spans neurological disorders, psychiatric conditions, and pain management, not just the most commonly studied indications.
Neurological Disorders
Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS), Canavan Disease, Friedreich's Ataxia, Migraine, Multiple Sclerosis (MS), Parkinson's Disease, and more
Psychiatry
Autism Spectrum Disorder, Depression, Mood Disorders, Post-Traumatic Stress Disorder, Smoking Cessation, Substance Abuse Disorder, Schizophrenia, and more
Pain Management
Acute Pain, Chronic Pain, Osteoarthritis Joint Pain, Opioid and Non-Opioid Pain, Post-Surgical Pain, and more
Neurology, Pain Management, and Psychiatry Experience in the Past 5 Years
70%
of global operations team members have neurology and psychiatry experience
200+
clinical trials & consulting projects in the past 5 years
20%
for rare/ultra-rare neurological disorders
PROOF & RESOURCES
Real Programs, Real Outcomes
A Practical Guide for Managing Multiple Global Regulatory Pathways
Learn More →
FDA Expedited Programs – What You Need to Know
Learn More →
Side-by-Side Comparison: Non-Adaptive vs. Adaptive Designs in ...
Learn More →
Frequently Asked Questions
What is making the next decision difficult in your neurology program?
Bring us the endpoint question, the recruitment challenge, the emerging data, or the regulatory uncertainty. We will help you turn it into a clearer path forward.